Skip to content

The application of patient reported outcomes in preventing relapse of depression

The application of patient reported outcomes in preventing relapse of depression

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018769
Enrollment
Unknown
Registered
2018-10-09
Start date
2018-04-01
Completion date
Unknown
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

PRO Group:self assessment
TAU Group:assessment based on doctors

Sponsors

Beijing Anding Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years old male and female outpatient; 2. Has a diagnosis of recurrent major depressive disorder by Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria,with no psychotic symptoms; 3. the depressive episode has been treated with an SSRI antidepressant for 6 to 12 weeks; 4. hamd-17< 14 in screening; 5. the education level above primary school can understand the content of the scale; 6. the patient signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Previous clear episodes of mania or hypomania; 2. Previous diagnoses of bipolar disorder, schizophrenia, schizoaffective disorder and mental disorders associated with other diseases; 3. Patients currently have a high risk of suicide (the risk of suicide of MINI6.0.0 B module is severe, or the item of hamd-17 suicide risk is greater than or equal to 3 points); 4. MECT, transcranial magnetic stimulation, antipsychotics, non-benzodiazepines, mood stabilizers were used during the depressive episode; 5. Patients with a history of alcohol dependence and acute poisoning; 6. Female patients during pregnancy or lactation; 7. At present, researchers of severe somatic diseases think it is not suitable for this study.

Design outcomes

Primary

MeasureTime frame
sustained response time;

Secondary

MeasureTime frame
relapse rate;compliance;

Countries

China

Contacts

Public ContactHu Chang-Qing

Beijing Anding Hospital Affiliated to Capital Medical University

coannhu@126.com+86 13661106500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026